Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Annals of Surgical Oncology|June 6, 2026
Survival Outcomes in Early Onset Appendiceal Adenocarcinoma (EOAA)Rushabh Gujarathi, Erika Belmont, Christopher Rodman, et al.
The Lancet. Gastroenterology & Hepatology|December 5, 2025
Tinengotinib for adults with advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 trialMilind Javle, Christos Fountzilas, Chih-Yi Liao, et al.
Annals of Surgical Oncology|January 6, 2022
Phase II Prospective, Open-Label Randomized Controlled Trial Comparing Standard of Care Chemotherapy With and Without Sequential Cytoreductive Interventions for Patients with Oligometastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor Deoxyribose Nucleic Acid (ctDNA) LevelsAnkit Dhiman, Charles C Vining, Hunter D D Witmer, et al.
Journal for Immunotherapy of Cancer|March 13, 2026
Phase Ib multicenter study of anti-TIM-3 (S095018/Sym023) in combination with anti-PD-1 (Sym021) in patients with advanced/metastatic recurrent biliary tract cancerFrancois Ghiringhelli, Richard Kim, Teresa Macarulla, et al.
Future Oncology (London, England)|June 11, 2024
COMPANION-002 A clinical trial of investigational drug CTX-009 plus paclitaxel vs paclitaxel in second line advanced BTCNilofer Azad, Zishuo Hu, Ilyas Sahin, et al.
Cancer Discovery|November 25, 2020
Personalized Antibodies for Gastroesophageal Adenocarcinoma (PANGEA): A Phase II Study Evaluating an Individualized Treatment Strategy for Metastatic DiseaseDaniel V T Catenacci, Stephanie Moya, Samantha Lomnicki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2021
Phase I Study of Stereotactic Body Radiotherapy plus Nivolumab and Urelumab or Cabiralizumab in Advanced Solid TumorsCorey C Foster, Gini F Fleming, Theodore G Karrison, et al.
JAMA Network Open|February 15, 2020
Evaluation of the Association of Perioperative UGT1A1 Genotype-Dosed gFOLFIRINOX With Margin-Negative Resection Rates and Pathologic Response Grades Among Patients With Locally Advanced Gastroesophageal Adenocarcinoma: A Phase 2 Clinical TrialDaniel V T Catenacci, Leah Chase, Samantha Lomnicki, et al.
Nature Medicine|March 28, 2024
A shared neoantigen vaccine combined with immune checkpoint blockade for advanced metastatic solid tumors: phase 1 trial interim resultsAmy R Rappaport, Chrisann Kyi, Monica Lane, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 30, 2025
Final Results from a First-in-Human Phase I Study of the Dual Isocitrate Dehydrogenase (IDH) 1/2 Inhibitor, LY3410738, in Advanced Solid Tumors Harboring IDH1 or IDH2 MutationsJames J Harding, Do-Youn Oh, Teresa Macarulla Mercade, et al.
Pageof 5